Tricyclic antidepressants, autonomic function and mortality in patients with coronary heart disease: data from the heart and soul study
Rationale/statement of the problem: Although tricyclic antidepressants (TCAs) are not recommended as first line therapy for depression in patients with coronary heart disease (CHD), they are still occasionally prescribed. Rationales may include resistance to other classes of antidepressants, previou...
Main Authors: | Linn Kristina Kuehl, Frank Zimmermann-Viehoff, Heidi Danker-Hopfe, Mary A. Whooley, Christian Otte |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2012-09-01
|
Series: | European Journal of Psychotraumatology |
Subjects: |
Similar Items
-
Poisoining with Tricyclic Antidepressants and Current Treatment
by: Muge Gulen
Published: (2016-12-01) -
Tricyclic Antidepressants and Sudden Death
by: J Gordon Millichap
Published: (1997-03-01) -
Cardiovascular Effects of Tricyclic Antidepressants
by: J Gordon Millichap
Published: (1996-11-01) -
ST-T segment changes in patients with tricyclic antidepressant poisoning
by: Farzad Gheshlaghi, et al.
Published: (2013-01-01) -
The Association between Antidepressant Medications and Coronary Heart Disease in Brazil: A Cross-sectional Analysis on the Brazilian Longitudinal Study of Adult Health (ELSA-Brazil)
by: Andrew eKemp
Published: (2015-01-01)